Among the over one hundred human methylation biomarkers tested, approximately ten have emerged as clinically relevant for the diagnosis, prognosis, and treatment of cervical cancer, including CADM1, EPB41L3, FAM19A4, MAL, miR-124, PAX1, and SOX1 [12]. Here, TAFA4 is linked to cervical cancer.